Ausdal Financial Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.84M | Buy |
5,230
+1,027
| +24% | +$366K | 0.08% | 241 |
|
|
2025
Q4 | $1.38M | Buy |
4,203
+896
| +27% | +$284K | 0.06% | 288 |
|
|
2025
Q3 | $933K | Buy |
3,307
+801
| +32% | +$232K | 0.05% | 377 |
|
|
2025
Q2 | $700K | Sell |
2,506
-557
| -18% | -$158K | 0.05% | 335 |
|
|
2025
Q1 | $954K | Buy |
3,063
+554
| +22% | +$164K | 0.07% | 249 |
|
|
2024
Q4 | $654K | Buy |
2,509
+1,008
| +67% | +$299K | 0.06% | 286 |
|
|
2024
Q3 | $483K | Sell |
1,501
-24
| -2% | -$7.85K | 0.05% | 313 |
|
|
2024
Q2 | $476K | Sell |
1,525
-159
| -9% | -$46.7K | 0.05% | 296 |
|
|
2024
Q1 | $479K | Sell |
1,684
-518
| -24% | -$152K | 0.06% | 279 |
|
|
2023
Q4 | $634K | Sell |
2,202
-519
| -19% | -$141K | 0.08% | 219 |
|
|
2023
Q3 | $731K | Buy |
2,721
+525
| +24% | +$131K | 0.1% | 187 |
|
|
2023
Q2 | $488K | Sell |
2,196
-29
| -1% | -$6.73K | 0.07% | 246 |
|
|
2023
Q1 | $538K | Sell |
2,225
-33
| -1% | -$8.1K | 0.07% | 235 |
|
|
2022
Q4 | $593K | Buy |
2,258
+96
| +4% | +$25.7K | 0.09% | 221 |
|
|
2022
Q3 | $487K | Buy |
2,162
+99
| +5% | +$24K | 0.08% | 246 |
|
|
2022
Q2 | $502K | Buy |
2,063
+85
| +4% | +$20.8K | 0.08% | 260 |
|
|
2022
Q1 | $478K | Buy |
1,978
+404
| +26% | +$92.8K | 0.07% | 290 |
|
|
2021
Q4 | $354K | Buy |
1,574
+392
| +33% | +$82.7K | 0.05% | 346 |
|
|
2021
Q3 | $251K | Buy |
1,182
+131
| +12% | +$30.2K | 0.04% | 393 |
|
|
2021
Q2 | $256K | Sell |
1,051
-22
| -2% | -$5.41K | 0.04% | 380 |
|
|
2021
Q1 | $267K | Buy |
1,073
+65
| +6% | +$15.5K | 0.05% | 361 |
|
|
2020
Q4 | $232K | Sell |
1,008
-91
| -8% | -$21K | 0.05% | 362 |
|
|
2020
Q3 | $279K | Buy |
1,099
+62
| +6% | +$15.4K | 0.07% | 274 |
|
|
2020
Q2 | $245K | Hold |
1,037
| – | – | 0.08% | 237 |
|
|
2020
Q1 | $245K | Sell |
1,037
-1,114
| -52% | -$243K | 0.09% | 222 |
|
|
2019
Q4 | $489K | Buy |
2,151
+13
| +0.6% | +$2.87K | 0.14% | 180 |
|
|
2019
Q3 | $414K | Sell |
2,138
-19
| -0.9% | -$3.65K | 0.15% | 182 |
|
|
2019
Q2 | $381K | Sell |
2,157
-544
| -20% | -$97.4K | 0.15% | 177 |
|
|
2019
Q1 | $513K | Buy |
2,701
+117
| +5% | +$22.3K | 0.21% | 126 |
|
|
2018
Q4 | $503K | Sell |
2,584
-1,194
| -32% | -$233K | 0.25% | 102 |
|
|
2018
Q3 | $783K | Buy |
3,778
+68
| +2% | +$13.4K | 0.22% | 136 |
|
|
2018
Q2 | $685K | Sell |
3,710
-278
| -7% | -$49.2K | 0.21% | 142 |
|
|
2018
Q1 | $680K | Buy |
3,988
+232
| +6% | +$42.6K | 0.24% | 126 |
|
|
2017
Q4 | $653K | Buy |
3,756
+166
| +5% | +$29.4K | 0.23% | 135 |
|
|
2017
Q3 | $669K | Sell |
3,590
-611
| -15% | -$108K | 0.27% | 112 |
|
|
2017
Q2 | $724K | Buy |
4,201
+705
| +20% | +$115K | 0.31% | 91 |
|
|
2017
Q1 | $574K | Buy |
3,496
+235
| +7% | +$39K | 0.26% | 100 |
|
|
2016
Q4 | $477K | Buy |
3,261
+99
| +3% | +$14.9K | 0.22% | 115 |
|
|
2016
Q3 | $527K | Buy |
3,162
+61
| +2% | +$10.3K | 0.27% | 108 |
|
|
2016
Q2 | $472K | Sell |
3,101
-260
| -8% | -$40.4K | 0.24% | 109 |
|
|
2016
Q1 | $504K | Buy |
3,361
+156
| +5% | +$23.2K | 0.29% | 94 |
|
|
2015
Q4 | $520K | Buy |
+3,205
| New | +$504K | 0.26% | 92 |
|
Other funds holding AMGN
VCM
VPM
Ausdal Financial Partners's AMGN Position: Q1 2026 in Review
Ausdal Financial Partners increased its Amgen (AMGN) stake by 24% in Q1 2026, buying an estimated $366K and bringing the position to 5,230 shares worth $1.84M. The position accounts for 0.08% of the portfolio, ranked #241.
Ausdal Financial Partners first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ausdal Financial Partners held 5,230 shares of Amgen worth $1.84M as of Q1 2026.
- Ausdal Financial Partners bought 1,027 Amgen shares in Q1 2026, an estimated $366K.
- Amgen made up 0.08% of Ausdal Financial Partners's portfolio in Q1 2026, its #241 holding.
- Ausdal Financial Partners first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.